Your browser doesn't support javascript.
loading
The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.
Farias, Jéssica P; Pinheiro, Josilene R; Andreata-Santos, Robert; Fogaça, Mayanna M C; da Silva Brito, Ruth D; da Cruz, Edgar F; de Castro-Amarante, Maria F; Pereira, Samuel S; Dos Santos Almeida, Shirley; Moreira, Ludimila M; da Conceição Simões, Rafael; Luiz, Wilson B; Birbrair, Alexander; Belmok, Aline; Ribeiro, Bergmann M; Maricato, Juliana T; Braconi, Carla T; de Souza Ferreira, Luís C; Janini, Luiz M R; Amorim, Jaime Henrique.
Afiliación
  • Farias JP; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • Pinheiro JR; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • Andreata-Santos R; Department of Biological Sciences, State University of Santa Cruz, Ilhéus, Brazil.
  • Fogaça MMC; Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • da Silva Brito RD; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • da Cruz EF; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • de Castro-Amarante MF; Division of Infectology, Medicine Department, Federal University of São Paulo, São Paulo, Brazil.
  • Pereira SS; Vaccine Development Laboratory, Microbiology Department, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • Dos Santos Almeida S; Scientific Platform Pasteur USP, University of São Paulo, São Paulo, SP, Brazil.
  • Moreira LM; Vaccine Development Laboratory, Microbiology Department, Biomedical Sciences Institute, University of São Paulo, São Paulo, Brazil.
  • da Conceição Simões R; Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
  • Luiz WB; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • Birbrair A; Center of Biological Sciences and Health, Federal University of Western Bahia, Barreiras, Brazil.
  • Belmok A; Department of Biological Sciences, State University of Santa Cruz, Ilhéus, Brazil.
  • Ribeiro BM; Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, Wisconsin, Madison, USA.
  • Maricato JT; Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Braconi CT; Department of Radiology, Columbia University Medical Center, New York, New York, USA.
  • de Souza Ferreira LC; Laboratory of Baculoviruses, Cell Biology Department, University of Brasilia, Brasília, Brazil.
  • Janini LMR; Laboratory of Baculoviruses, Cell Biology Department, University of Brasilia, Brasília, Brazil.
  • Amorim JH; Department of Microbiology, Immunology and Parasitology, Paulista School of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
J Med Virol ; 95(2): e28481, 2023 02.
Article en En | MEDLINE | ID: mdl-36609686
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos